MX6290E - Procedimiento mejorado para la preparacion de una vacuna contra la hepatitis viral tipo b - Google Patents

Procedimiento mejorado para la preparacion de una vacuna contra la hepatitis viral tipo b

Info

Publication number
MX6290E
MX6290E MX798052U MX805279U MX6290E MX 6290 E MX6290 E MX 6290E MX 798052 U MX798052 U MX 798052U MX 805279 U MX805279 U MX 805279U MX 6290 E MX6290 E MX 6290E
Authority
MX
Mexico
Prior art keywords
preparing
viral hepatitis
improved procedure
hepatitis vaccine
vaccine type
Prior art date
Application number
MX798052U
Other languages
English (en)
Inventor
Alfred Mayer Prince
John Andrew Vnek
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of MX6290E publication Critical patent/MX6290E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation
    • C12N2730/10162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX798052U 1978-06-07 1979-06-06 Procedimiento mejorado para la preparacion de una vacuna contra la hepatitis viral tipo b MX6290E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91342278A 1978-06-07 1978-06-07

Publications (1)

Publication Number Publication Date
MX6290E true MX6290E (es) 1985-03-18

Family

ID=25433258

Family Applications (1)

Application Number Title Priority Date Filing Date
MX798052U MX6290E (es) 1978-06-07 1979-06-06 Procedimiento mejorado para la preparacion de una vacuna contra la hepatitis viral tipo b

Country Status (8)

Country Link
EP (1) EP0005864B1 (es)
JP (1) JPS54160716A (es)
AT (1) ATE313T1 (es)
AU (1) AU530195B2 (es)
CA (1) CA1117010A (es)
DE (1) DE2961060D1 (es)
MX (1) MX6290E (es)
ZA (1) ZA792485B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268122B1 (en) 1978-12-22 2001-07-31 Biogen, Inc. Recombinant DNA molecules and their method of production
JPH0625069B2 (ja) * 1981-01-29 1994-04-06 ブリティッシュ・テクノロジー・グループ・リミテッド Ｂ型肝炎ワクチン製造方法
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
WO1985004103A1 (en) * 1984-03-09 1985-09-26 Scripps Clinic And Research Foundation Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
WO1993005811A1 (en) * 1991-09-18 1993-04-01 Amgen Inc. A hepatitis b vaccine formulation incorporating a bile acid salt
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1012445B (it) * 1973-05-21 1977-03-10 Siderurgie Fse Inst Rech Procedimento per la dissulfurazione dei metalli fusi
JPS5714653B2 (es) * 1974-06-21 1982-03-25
SE437329B (sv) * 1975-03-14 1985-02-25 Community Blood Council Sett att ur blodserum framstella vaccin mot virushepatit
US4017360A (en) * 1975-05-14 1977-04-12 Merck & Co., Inc. Method for purifying hepatitis B antigen
GB1518582A (en) * 1975-11-17 1978-07-19 Community Blood Council Viral hepatitis vaccine
JPS53104724A (en) * 1977-02-23 1978-09-12 Green Cross Corp:The Preparation of uniform hbsag particles

Also Published As

Publication number Publication date
ZA792485B (en) 1980-06-25
AU530195B2 (en) 1983-07-07
ATE313T1 (de) 1981-11-15
EP0005864A1 (en) 1979-12-12
EP0005864B1 (en) 1981-10-21
DE2961060D1 (en) 1981-12-24
AU4767179A (en) 1979-12-13
JPS54160716A (en) 1979-12-19
CA1117010A (en) 1982-01-26

Similar Documents

Publication Publication Date Title
MA21911A1 (fr) Procede pour produire une grande proteine de surface modifiee du virus de l'hepatite b .
GB2091938B (en) Micro defelctor sub-assembly for use in electron beam tubes of the fly'eye type
MX6290E (es) Procedimiento mejorado para la preparacion de una vacuna contra la hepatitis viral tipo b
KR860004146A (ko) 경구용 백신의 제조방법
FI823021A7 (fi) Tuotteet, jotka osoittavat hepatitis B virus e antigeenin antigeenisuuden ja menetelmät näiden antigeenien vavalmistamiseksi.
JPS5663922A (en) Feline infectious peritonitis virus* vaccine obtained therefrom* its manufacture and use
FI880802A7 (fi) Hepatitis B-viruspinta-antigeenin esi-S-alueen T- ja B-soluepitoopit.
SE7602871L (sv) Vaccin for aktiv immunisering
GB1557668A (en) Virus insecticide compositions
NZ192270A (en) Attenuated strain of feline infectious peritonitis virus and vaccine
GB1442564A (en) Process for preparing inactivated hb ag vaccine
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
ES460321A1 (es) Metodo para la preparacion de mutante viral no virulento, del virus aujeszky.
JPS529182A (en) Dust precipitator
DE3750330D1 (de) Verfahren zur Herstellung eines Impfstoffs gegen Hepatitis B.
JPS5239951A (en) Heater of absorption type
JPS5248276A (en) Brush of vacuum cleaner
GR23945B (el) Τελειοποιησεις εις η εν σχεσει προς απορρυπαντικας συνθεσεις και παρασκευη τουτων.
DK90128C (da) Fremgangsmåde til fremstilling af en vandig vævskulturvæske, indeholdende en høj koncentration af levende >>smitsom hepatitis<<-virus.
RO82518B1 (ro) Procedeu de obtinere a vaccinului contra bolii lui carre
JPS51142961A (en) Activating photo-electric surface of iii-v family compound